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by ancillary measures in maintaining the transmissibility of the infection is
discussed.
The expenses of this research were defrayed by the British Empire Cancer
Campaign.
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IT was previously shown, in following up the mechanism ofthe co-carcinogenic
action of croton oil (Berenblum, 1941 a and b), that the latent period of tumour
induction, following an adequate period of painting of the mouse's skin with a
carcinogen, was not influenced when preceded by 26 weeks of croton oil applica-
tions. Yet, a significant increase in tumour incidence was observed when the
croton oil treatment was given subsequent to a sub-optimal period (8 weeks) of
painting with a carcinogen. It was concluded that two independent processes
were involved in the evolution ofa visible wart: aprecarcinogenic action, elicited
by carcinogens but not by croton oil, and therefore of a specific nature; and an
epicarcinogenic action, representing the formation of a visible tumour (wart)
at a site previously " prepared " by sub-optimal treatment with a carcinogen,
and elicited by a non carcinogenic agent, such as croton oil, as readily as by
continued application of the carcinogen itself, and therefore non-specific (Beren-
blum, 1941b,; 1944).
The problem was further investigated by Mottram (1944 a and b), who
claimed (a) that the procedure could be simplified, in that a sin,gle application
of a carcinogen (3:4-benzpyrene), followed by repeated applications of croton
oil, was sufficient to lead to tumour production; and (b) that this effect was
accentuated when the croton oil was applied before as well as after the singleI. BERENBLUM AND P. SHUBIK
application of the carcinogen. Mottram concluded that carcinogenesis was
composed of 3 phases:
(1) A " Sensitizing Factor," which could be brought about by pre-
liminary treatment with croton oil, acting presunmably in a non-specific
manner by causing hyperplasia, on the supposition that proliferating
cells were more responsive than resting cells to the specific carcinogenic
action which followed.
(2) A " Specific Cellular Reaction," induced by the specific action
(even of a single application) of a carcinogen, this representing the
essential neoplastic change.
(3) A " Developing Factor," responsible for the actual appearance of
a visible wart, and produced by croton oil or by a carcinogen.
Thus, Mottram's second stage (" Specific Cellular Reaction ") corresponds
to the " Precarcinogenic Action " of Berenblum (1941b; 1944) and also to the
"Initiating Process " of Friedewald and Rous (1944), while his third stage
(" Developing Factor ") corresponds to Berenblum's " Epicarcinogenic Action "
and Friedewald and Rous's " Promoting Process." (See Table of corresponding
nomenclatures, Berenblum, 1947.) However, Mottram's first-stage (" Sensitizing
Factor ") is a new concept, not brought out by any of the previous workers.
Unfortunately, his results were based on experiments which, owing to the pre-
vailing war-time conditions, were performed on inadequate numbers of animals,
and therefore call for confirmation.
The present work constitutes a repetition and extension of Mottram's experi-
ments, designed to test the two principal claims:
(a) whether a single application of a carcinogen is indeed adequate
antecedent treatment to allow the " developing " effect of croton oil to
be manifested; and
(b) whether there is in fact an initial, non-specific, hyperplasia-produc-
ing, " sensitizing factor," operating prior to the specific carcinogenic
action.
METHODS.
Mice of mixed strain (white and coloured) from this laboratory stock were
used, and were maintained throughout the experiment on an adequate mixed
diet. The experimental area of skin, in the interscapular region, was clipped
periodically with fine scissors for the removal of hair, and the test solutions
applied with a glass rod.
In order to diminish variability in response, all reagents were applied in the
form of solutions in the non-volatile liquid paraffin, instead of in such volatile
solvents as acetone or benzene. This necessitated, however, the use of higher
concentrations, as was demonstrated elsewhere (Berenblum and Schoental,
1947).
EXPERIMENTAL.
In the first experiment two groups of mice were treated as follows:
Group A: 50 mice were given paintings of 5 per cent croton oil in
liquid paraffin twice-weekly for two weeks, then given a single painting
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of 0 8 per cent 3:4-benzpyrene in liquid paraffin, and then painted twice-
weekly for 20 weeks with the croton oil solution.
Group B: 45 mice were given identical treatment to those of Group A,
except for the omission of the pre-painting with croton oil.
TABLE I.
Treatment. * Number Survivors at Number of Percentage of Average
Series. -~--- of mice time of mice with mice bearinig latentperiodt
a. b. c. used. 1st tumour. tumours. tumours. (weeks).
A . Cr. oil BP Cr. oil . 50 . 45 . 12 . 26-5 . 10 8
B . - ,, ,, 45 . 40 . 15 . 37 5 . 10 6
I .Cr. oil DMBA ,, 48 . 42 . 24 . 57 8-1
II . - ,, ,, . 45 . 37 . 20 . 54 7 - 5
III .Cr. oil ,, . 46 . (35) * 0 . 0
IV . - 45 . 38 1 . 2-6 -
V .Cr. oil Cr. oil. 48 . (41) . 0 . 0
* Colunm a: 5 per cent croton oil in liquid paraffin twice-weekly for 2 weeks.
,, b: BP = 0.8 per cent benzpyrene in liquid paraffin applied once only.
DMBA = 1-5 per cent 9:10-dimethyl-1:2-benzanthracene in liquid
paraffin applied once only.
,, c: 5 per cent croton oil in liquid paraffin twice-weekly for 20 weeks.
Latent period counted from time of commencement of application of second croton
oil treatment.
From Table I it can be seen that there Was little difference between the two
groups, either in the total number of tumours induced or in the relative latent
periods of tumour induction. The small differences observed are not significant,
and, in any case, are the opposite to those reported by Mottram, since the animals
pre-treated with croton oil actually developedfewer tumours than those without
pre-treatment.
A second, and more elaborate, experiment was carried out, in which a 1-5 per
cent solution in liquid paraffin of 9:10-dimethyl-1:2-benzanthracene (DMBA)
was used as the carcinogen (single painting); and the experiment also included
three additional control groups
Group I: 48 mice were painted twice-weekly for 2 weeks with croton
oil, then given one application of DMBA, and then painted twice-weekly
with croton oil for a further 20 weeks.
Group II: 45 mice were treated as those in Group I, except for the
omission of pre-painting with croton oil.
Group III: 46 mice were given croton oil for 2 weeks, twice-weekly,
and then 1 application of DMBA, but not followed by croton oil treat-
ment.
Group IV: 45 mice were given a single application of the carcinogen
(DMBA), and nothing else.
Group V: 48 mice received croton oil twice-weekly for 23 weeks
(i.e. similar to those in Group I, except for the omission of application of
DMBA).
It can be seen (Table T) that, here again, no significant difference in tumour
yield between those pre-treated with croton oil (Group I) and those without382 I. BERENBLUM AND P. SHUBIK
such pre-treatment (Group II). In the control groups no tumours developed
except for an isolated tumour in Group IV.
DISCUSSION.
The results described above lend no support to the assumption that an
induced hyperplasia preceding the painting of a carcinogen has any augmenting
influence on experimental tumour induction. This would seem to eliminate
Mottram's postulated " Sensitizing Factor."
On the other hand, Mottram's other result, that a single application of a
carcinogen, followed by applications of the irritant, croton oil, will induce
tumours, received confirmation. This latter finding accords well with both
Berenblum's and Rous's concepts of a " precarcinogenic " or " initiating "
phase, followed by an " epicarcinogenic " or " promoting " phase.
Mottram's simplification of procedure (involving- a single application of a
carcinogen) has important technical significance, enabling the. various phases of
carcinogenesis to be analysed in a more accurate and quantitative fashion than
has, up to the present, been possible (Berenblum and Shubik, 1947.)
SUMMARY.
1. Mottram's finding that a single application of 3:4-benzpyrene, followed
by repeated applications of croton oil, will induce tumours, is confirmed, and is
shown to hold also for 9:10-dimethyl-1:2-benizanthracene.
2. Mottram's other observation, that non-specific hyperplasia, induced by
croton oil previou8 to the single application of a carcinogen, leads to an increase
in the number of tumours induced, is not confirmed.
We wish to thank Mr. H. W. Wheal for technical assistance and the care of
the animals.
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